主题：【悬赏帖】求助英文文献若干篇

【序号】：1
【作者】：Okada H1, Inoue Y, Heya T, Ueno H, Ogawa Y, Toguchi H.
【题名】：Pharmacokinetics of once-a-month injectable microspheres of leuprolide acetate.
【期刊】：Pharm Res.
【年、卷、期、起止页码】: 1991 Jun;8(6):787-91.
【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/1905810
【序号】：2
【作者】：Taguchi T1, Koyama H, Yayoi K, Wada T, Takatsuka Y, Sonoo H, Morimoto K, Tominaga T, Abe R,
Enomoto K, et al.
【题名】：[Long-term clinical study on TAP-144-SR, an LH-RH agonist depot formulation, in premenopausal
patients with advanced or recurrent breast cancer. TAP-144-SR Breast Cancer Study Group].
【期刊】：Gan To Kagaku Ryoho.
【年、卷、期、起止页码】:1995 Mar;22(4):495-508.
【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/7887641
【序号】：3
【作者】：Niijima T1, Aso Y, Akaza H, Fujita K, Fuse H, Hosaka M, Isurugi K, Kamidono S, Katayama T,
Kawabe K, et al.
【题名】：[Clinical phase I and phase II study on a sustained release formulation of leuprorelin acetate
(TAP-144-SR), an LH-RH agonist, in patients with prostatic carcinoma. Collaborative++ Studies on
Prostatic Carcinoma by the Study Group for TAP-144-SR].
【期刊】：Hinyokika Kiyo.
【年、卷、期、起止页码】:1990 Nov;36(11):1343-60.
【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/2126912
【序号】：4
【作者】：D'Souza S1, Faraj JA, Dorati R, DeLuca PP.
【题名】：A short term quality control tool for biodegradable microspheres.
【期刊】：AAPS PharmSciTech.
【年、卷、期、起止页码】:2014 Jun;15(3):530-41. doi: 10.1208/s12249-013-0052-0. Epub 2014 Feb 12.
【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/24519488
【序号】：5
【作者】：Mashayekhi R1, Mobedi H, Najafi J, Enayati M.
【题名】：In-vitro/In-vivo comparison of leuprolide acetate release from an in-situ forming plga system.
【期刊】：Daru.
【年、卷、期、起止页码】:2013 Jul 15;21(1):57. doi: 10.1186/2008-2231-21-57.
【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/23856431
【序号】：6
【作者】：Schoubben A1, Blasi P, Deluca PP.
【题名】：Effect of agitation regimen on the in vitro release of leuprolide from poly(lactic-co-glycolic)
acid microparticles.
【期刊】：J Pharm Sci.
【年、卷、期、起止页码】:2012 Mar;101(3):1212-20. doi: 10.1002/jps.23029. Epub 2011 Dec 21.
【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/22189694
【序号】：7
【作者】：D'Souza SS1, Faraj JA, DeLuca PP.
【题名】：A model-dependent approach to correlate accelerated with real-time release from biodegradable
microspheres.
【期刊】：AAPS PharmSciTech.
【年、卷、期、起止页码】:2005 Oct 31;6(4):E553-64.
【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/16408857
【序号】：8
【作者】：D'Souza SS1, DeLuca PP.
【题名】：Development of a dialysis in vitro release method for biodegradable microspheres.
【期刊】：AAPS PharmSciTech.
【年、卷、期、起止页码】:2005 Oct 6;6(2):E323-8.
【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/16353991
【序号】：9
【作者】：Periti P1, Mazzei T, Mini E.
【题名】：Clinical pharmacokinetics of depot leuprorelin.
【期刊】：Clin Pharmacokinet.
【年、卷、期、起止页码】:2002;41(7):485-504.
【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/12083977
【序号】：10
【作者】：Shameem M1, Lee H, DeLuca PP.
【题名】：A short term (accelerated release) approach to evaluate peptide release from PLGA depot-
formulations.
【期刊】：AAPS PharmSci.
【年、卷、期、起止页码】:1999;1(3):E7.
【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/11741203
【序号】：11
【作者】：Okada H1.
【题名】：One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin
acetate.
【期刊】：Adv Drug Deliv Rev. 1
【年、卷、期、起止页码】:1997 Oct 13;28(1):43-70.
【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/10837564
【序号】：12
【作者】：Verspyck E1, Marpeau L, Lucas C.
【题名】：Leuprorelin depot 3.75 mg versus lynestrenol in the preoperative treatment of symptomatic
uterine myomas: a multicentre randomised trial.
【期刊】：Eur J Obstet Gynecol Reprod Biol.
【年、卷、期、起止页码】:2000 Mar;89(1):7-13.
【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/10733017
【序号】：13
【作者】：Tunn UW1, Bargelloni U, Cosciani S, Fiaccavento G, Guazzieri S, Pagano F.
【题名】：Comparison of LH-RH analogue 1-month depot and 3-month depot by their hormone levels and
pharmacokinetic profile in patients with advanced prostate cancer.
【期刊】：Urol Int.
【年、卷、期、起止页码】:1998;60 Suppl 1:9-16; discussion 16-7.
【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/9563139
【序号】：14
【作者】：Takada S1, Ogawa Y.
【题名】：.
【期刊】：Nihon Rinsho.
【年、卷、期、起止页码】:1998 Mar;56(3):675-9.
【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/9549355
【序号】：15
【作者】：Saruki K1, Sekihara T, Mashimo M, Matsuo H, Sekiguchi H.
【题名】：Leuprorelin acetate blood levels and dialysance after the administration of sustained-release
leuprorelin acetate in a dialysis case complicated by prostate cancer.
【期刊】：Prostate.
【年、卷、期、起止页码】:1998 Feb 15;34(3):191-4.
【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/9492847
【序号】：16
【作者】：Okada H1, Doken Y, Ogawa Y, Toguchi H.
【题名】：Preparation of three-month depot injectable microspheres of leuprorelin acetate using
biodegradable polymers.
【期刊】：Pharm Res.
【年、卷、期、起止页码】:1994 Aug;11(8):1143-7.
【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/7971715
【序号】：17
【作者】：Okada H1, Doken Y, Ogawa Y, Toguchi H.
【题名】：Sustained suppression of the pituitary-gonadal axis by leuprorelin three-month depot
microspheres in rats and dogs.
【期刊】：Pharm Res.
【年、卷、期、起止页码】:1994 Aug;11(8):1199-203.
【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/7971724
【序号】：18
【作者】：Toguchi H1.
【题名】：Formulation study of leuprorelin acetate to improve clinical performance.
【期刊】：Clin Ther.
【年、卷、期、起止页码】:1992;14 Suppl A:121-30.
【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/1606592
【序号】：19
【作者】：Asano M1, Fukuzaki H, Yoshida M, Kumakura M, Mashimo T, Yuasa H, Imai K, Yamanaka H.
【题名】：In vivo characteristics of low molecular weight copoly (D,L-lactic acid) formulations with
controlled release of LH-RH agonist.
【期刊】：Biomaterials.
【年、卷、期、起止页码】:1989 Oct;10(8):569-73.
【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/2513891
【序号】：20
【作者】：Ogawa Y1, Okada H, Heya T, Shimamoto T.
【题名】：Controlled release of LHRH agonist, leuprolide acetate, from microcapsules: serum drug level
profiles and pharmacological effects in animals.
【期刊】：J Pharm Pharmacol.
【年、卷、期、起止页码】:J Pharm Pharmacol. 1989 Jul;41(7):439-44.
【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/2570847